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Abstract
Background: Polyethyleneimine (PEI), a cationic polymer, is one of the successful and widely used
vectors for non-viral gene transfection in vitro. However, its in vivo application was greatly limited
due to its high cytotoxicity and short duration of gene expression. To improve its biocompatibility
and transfection efficiency, PEI has been modified with PEG, folic acid, and chloroquine in order to
improve biocompatibility and enhance targeting.
Results:  Poly(ε-caprolactone)-Pluronic-Poly(ε-caprolactone) (PCFC) was synthesized by ring-
opening polymerization, and PCFC-g-PEI was obtained by Michael addition reaction with GMA-
PCFC-GMA and polyethyleneimine (PEI, 25 kD). The prepared PCFC-g-PEI was characterized by
1H-NMR, SEC-MALLS. Meanwhile, DNA condensation, DNase I protection, the particle size and
zeta potential of PCFC-g-PEI/DNA complexes were also determined. According to the results of
flow cytometry and MTT assay, the synthesized PCFC-g-PEI, with considerable transfection
efficiency, had obviously lower cytotoxicity against 293 T and A549 cell lines compared with that
of PEI 25 kD.
Conclusion: The cytotoxicity and in vitro transfection study indicated that PCFC-g-PEI copolymer
prepared in this paper was a novel gene delivery system with lower cytotoxicity and considerable
transfection efficiency compared with commercial PEI (25 kD).
Background
Gene therapy is being studied world-widely during the
past 20 years. In almost all of experiments and clinical
treatments, gene therapy requires delivering therapeutic
gene into target cells to correct gene defects and achieve
the purpose of treating diseases by using delivery carriers.
People have never stopped pursuing more safe and effi-
cient vector for gene delivery in gene therapy [1,2]. Gene
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delivery vectors can be generally divided into viral and
non-viral vectors. Due to its high transfection efficiency,
viruses were widely used before the potentially risk
became serious [3]. The use of non-viral vectors may
resolve some of the current problems associated with
virus vector, such as safety risks. Due to lack of immuno-
genicity and improved transfection efficiency, non-viral
vector is believed to be superior to viral gene delivery [4].
Non-viral vectors are ordinarily cationic that can con-
dense negatively charged DNA into nano-complexes
through electrostatic interaction. As a result, it can protect
DNA from nuclease digestion, and thus enhance the
expression of functional gene within the target cells.
Therefore, various polycations were synthesized and have
been investigated as gene carrier, including poly(L-lysine)
[5], poly(aminoester) [6] and poly(propylene imine)
(PPI) [7], polyethyleneimine [8-11], and etc. In all of the
non-viral gene vectors, polyethyleneimine was regarded
as a potential candidate with considerable transfection
efficiency [8], but PEI has high cytotoxicity and short
duration of gene expression [9-11]. Practically, transfec-
tion efficiency and cytotoxicity are almost antagonistic.
PEI with low molecular weight (molecular weight = 800
Da, 2000 Da, or less) shows lower cytotoxicity and lower
transfection efficiency, whereas PEI with high molecular
weight (25 kD) shows higher transfection efficiency and
higher cytotoxicity [12,13]. A novel gene delivery system
needs to balance the transfection efficiency and cytotoxic-
ity. Considerable attempts have been made to modify PEI
in order to improve the biocompatibility, targeting and
gene transfection efficiency [14-20]. Here we adopted the
biodegradable and biocompatible PCFC to modify PEI to
increase the transfection efficiency and decrease the cyto-
toxicity of PEI. Pluronic have been confirmed to increase
the in vitro transfection efficiency and enhance the trans-
gene expression in vivo [21,22]. Furthermore, due to graft-
ing with Pluronic, biocompatibility of the polymer might
be improved similar to the mechanism of PEGylation
[23]. Zhao et al. [24] had reported cationic PCFC nano-
particles could condense DNA and have potential applica-
tion as gene carrier with low cytotoxicity.
In this study, a novel poly(ε-caprolactone)-pluronic-
poly(ε-caprolactone) grafted polyethyleneimine copoly-
mer (PCFC-g-PEI) was synthesized and characterized.
Meanwhile, the DNA condensation ability, protection
ability, size and zeta potential of the PCFC-g-PEI/DNA
complexes were detected. In addition, we observed con-
siderable transfection efficiency and lower cytotoxicity of
PCFC-g-PEI compared with PEI 25 kD.
Results and discussion
Synthesis of PCFC-g-PEI
The aim of this study was to design and investigate an effi-
cient non-viral gene carrier modified with PCFC. The
PCFC-g-PEI copolymer was prepared according to Fig. 1 at
three steps. At the first step of PCFC synthesis (Fig. 1-a),
we chosen Pluronic 105 because it had satisfactory water-
solubility; and the PCFC concentration in this copolymer
had been optimized in prior research [24]. PCFC-g-PEI
was prepared from PEI and PCFC, and the reaction
scheme was shown in Fig. 1-c.
The  1H-NMR spectrum of PCFC macromonomer was
shown in Fig. 2-a. The peaks at 1.14, 3.42, and 3.50 ppm
were attributed to protons of -CH3, -CHR-, and -CH2- in
PPG unit of Pluronic block, respectively. The sharp peak
at 3.65 ppm is attributed to methylene protons of -
CH2CH2O- in PEG unit of Pluronic block. Peaks at 1.40,
1.65, 2.30 ppm, and 4.06 ppm are assigned to methylene
protons of -(CH2)3-, -COCH2-, and -CH2OOC- in PCL
blocks, respectively. The very weak peaks at 4.23 and 3.82
ppm are respectively attributed to methylene protons of -
OCH2CH2- in PEG end unit linked with PCL blocks. The
signals at 6.13 and 5.60 ppm corresponded to the protons
of the double bonds and the signals at 1.4, 2.3, and 4.1
ppm corresponded to the protons of PCL segment respec-
tively. The signal at 3.65 ppm corresponded to methylene
proton of HOCH2- end group of PCL-GMA macromono-
mer. The 1H-NMR spectrum of PCFC-g-PEI macromono-
mer was shown in Fig. 2-b. Chemical shifts at 2–3 ppm of
the 1H-NMR spectrums are attributed to the protons of -
NHCH2CH2- of PEI. The chemical shifts at 3–4 ppm are
attributed to the protons of Pluronic segment; the chemi-
cal shifts at 1–2 ppm and 4–5 ppm are attributed to the
protons of PCL respectively. The molecular weight of the
PCFC-g-PEI was determined by SEC in combination with
multiple angle laser light scattering (MALLS) (Fig. 3). The
absolute molecular weight was calculated by Astra soft-
ware. The Mn of PCFC-g-PEI was determined as 4.3 × 104,
whereas Mw was 1.0 × 105.
Agarose gel electrophoresis
The capacity to condense negatively charged DNA and
protect DNA against DNase I degradation is necessary
requirement for gene carriers. In this study, we character-
ized these abilities of PCFC-g-PEI by agarose gel electro-
phoresis. Fig. 4 showed agarose gel electrophoresis of
PCFC-g-PEI/DNA complexes at various N/P ratios, and
naked DNA was used as control. The N/P ratios of PCFC-
g-PEI/DNA were 0.5, 1, 2, and 3, respectively, where the
content of DNA was kept at 0.3 μg. As shown in Fig. 4-a,
in contrast to the naked plasmid DNA, the migration of
plasmid was completely blocked at the N/P ratio 1. In Fig.
4-b, the capability of protecting plasmid DNA from
DNase degradation was examined using DNase I as modelBMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
Page 3 of 12
(page number not for citation purposes)
a) Synthesis scheme of PCL-Pluronic-PCL (PCFC) Figure 1
a) Synthesis scheme of PCL-Pluronic-PCL (PCFC). b) Synthesis scheme of GMA- PCFC-GMA; c) Synthesis scheme of 
PCFC-g-PEI.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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1H-NMR spectrum (400 MHz) of PCL-Pluronic-PCL copolymer and PCFC-g-PEI in CDCl3 Figure 2
1H-NMR spectrum (400 MHz) of PCL-Pluronic-PCL copolymer and PCFC-g-PEI in CDCl3.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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Analysis of the PCFC-g-PEI by SEC-MALLS in 0.5 M sodium acetate-acetic acid Figure 3
Analysis of the PCFC-g-PEI by SEC-MALLS in 0.5 M sodium acetate-acetic acid. The signals shown were detected 
by a refractive index detector.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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enzyme. Heparin was used as a strong negative reagent to
destroy the PCFC-g-PEI/DNA complex and hence the plas-
mid DNA could be released. After incubated with DNase I
(1 unit) in DNase/Mg2+ digestion buffer at 37°C for 20
min, naked plasmid DNA showed significant degrada-
tion, while the plasmid DNA released from PCFC-g-PEI/
DNA complexes (N/P = 3) remained intact. According to
Fig. 4-a and Fig. 4-b, we can conclude that the PCFC-g-PEI
copolymer can concentrate DNA at low N/P ratio and pro-
tect DNA from degradation by DNase-I.
Size and zeta potential of the PCFC-g-PEI/DNA complexes
The size and zeta potential of the PCFC-g-PEI/DNA com-
plexes are important factors for cell uptake [9]. Many fac-
tors could affect the results such as the concentration of
DNA and polycations, the volumes of the complexes solu-
tion, the different sequences of addition of the reagents
and also the speed of mixing. In this experiment, we chose
deionized water as media when diluting and mixing
PCFC-g-PEI with DNA, which was slightly different from
some literatures [25]. According to Table 1 and Table 2,
we found that the complexes of PCFC-g-PEI/DNA and
PEI/DNA showed significant differences in size: when N/
P ratio was below 10, the size of PCFC-g-PEI/DNA com-
plexes was relatively stable around 200 nm, whereas the
size of PEI/DNA complexes fluctuated from 90 nm to 160
nm. With increase in N/P ratio to 15 later, both of these
complexes shown strong fluctuation. However, PCFC-g-
PEI/DNA and PEI/DNA complexes showed the same
trend in zeta potential change. With increase in content of
PCFC-g-PEI, the zeta potential of PCFC-g-PEI/DNA com-
plexes decreased until N/P ratio reached 10, and then it
rebound to 7.8 mV. These results suggested that the DNA
condensation ability was strongly increased at higher N/P
ratio, In addition, we found that the zeta potential of
these complexes was greatly affected by many factors such
as mixing time, mixing sequence, and etc. All results in
this part were measured three times and revised.
Atomic force microscopy
The surface morphology of the PFCF-g-PEI/DNA com-
plexes was determined by atomic force microscopy. As
shown in Fig. 5, the complex of PCFC-g-PEI/DNA was dis-
tributed uniformly and the spherical nanoparticles were
around 180 nm in diameter at N/P ratio 7.
In vitro transfection
The 293 T and A549 cells were seeded at 2 × 105 cells/well
in 6-well plates and maintained at 37°C with 5% CO2
until the degrees of fusion reached 60%. Each experiment
used the same protocol and the concentration of plasmid
DNA was kept at 2 μg. After transient transfection and
additional incubation for 24 h, transfection images were
observed by Fluorescence Inverted Microscope (IX71,
OLYMPUS), and photographed by using Spot Flex (Fig.
6), and transfection efficiency was quantitatively analyzed
(a) Agarose gel electrophoresis of PCFC-g-PEI/DNA com- plexes at various N/P ratios Figure 4
(a) Agarose gel electrophoresis of PCFC-g-PEI/DNA 
complexes at various N/P ratios. (b) Electrophoretic 
mobility analysis of PCFC-g-PEI/DNA complexes after 
DNase I treatment. DNA was released by adding 1 mg/ml 
heparin to the PCFC-g-PEI/DNA complexes. Both (a) and (b) 
used naked DNA as control.
Table 1: The particle size of PCFC-g-PEI/DNA complexes, with PEI/DNA complexes as control. (SD = 3)
Particle size (nm) (± SD)
Samples N/P = 1 N/P = 3 N/P = 5 N/P = 7 N/P = 10 N/P = 15
PCFC-g-PEI/pDNA complexes 208.05 ± 15.55 211.85 ± 11.95 215.3 ± 12.2 195.35 ± 6.95 161.4 ± 23.2 234.85 ± 10.25
PEI/pDNA complexes 118.5 ± 2.5 88.89 ± 0.83 99.115 ± 3.885 136.35 ± 4.45 159.1 ± 5.7 98.59 ± 9.81BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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using flow cytometry (FCM). The highest transfection effi-
ciency was observed in 293 T cell line which the efficiency
reached 50.7%, while in A549 the transfection efficiency
was 28.4% (Fig. 7).
Transfection efficiency depends on the charge ratio
between PCFC-g-PEI and DNA. With optimizing N/P
ratio, the transfection efficiency improved. In our work,
the optimal N/P ratios of PCFC-g-PEI/DNA were 3 to 5,
while that of PEI previously reported was 7 to 13[8]. The
reason that PCFC-g-PEI/DNA had higher transfection effi-
ciency at lower N/P ratio might be due to the high amine
content because that PCFC-g-PEI was cascade connection
using PEI 25 kD. There are less free elements when bind-
ing with DNA in transfection experiment so that the tox-
icity of PCFC-g-PEI will be reduced lower than that of PEI
as the N/P ratio increased by observation [26]. In addi-
tion, as a Pluronic grafted copolymer, Pluronic 105 was
contained in the PCFC complex and could be degraded in
acid, it had been reported that Pluronic block copolymer
exhibit valuable biological activities such as enhancing
sealing of cell membranes permeated by ionizing radia-
tion and electroporation thus preventing cellular necrosis
[27,28], and could also enhance polycation-mediated
gene transfer in vitro [29]. Due to these advantages,
though the content of relative primary amine was
decreased, the transfection efficiency did not decreased
significantly according to our results.
Cytotoxicity
The cytotoxicity caused by PCFC-g-PEI (25 kD) and PEI
(25 kD) were assessed by MTT assay (Fig. 8) and propid-
ium iodide (PI) staining and flow cytometry (Fig. 9). MTT
assay shows that complexes of PCFC-g-PEI have lower
cytotoxicity than that of PEI 25 kD in two cell lines, 293 T
and A549. It is confirmed that the cyto-compatibility of
PCFC-g-PEI improved as compared with PEI 25 kD. In
both cell lines, the tolerance of the gene delivery vector
had increased to a different degree. The 293 T cell line was
the most sensitive that demonstrated the biggest differ-
ence on tolerance between PCFC-g-PEI and PEI 25 kd. At
the concentration of 5, 7 and 10 mg/ml, PCFC-g-PEI did
not show apparent cytotoxicity, while the survival rate of
PEI control group was approximately 40%. For the A549
cell line, both groups of PCFC-g-PEI and PEI showed
higher tolerance than 293 T; and at the concentration of
10 μg/ml the cell viability of PCFC-g-PEI were greater than
80%, while the cell viability of PEI was just 70%. Many
Table 2: Zeta potential of PCFC-g-PEI/DNA complexes, with PEI/DNA complexes as control. (SD = 3)
Zeta potential (mV) (± SD)
Samples N/P = 1 N/P = 3 N/P = 5 N/P = 7 N/P = 10 N/P = 15
PCFC-g-PEI/pDNA complexes 31.2 ± 2.1 16.75 ± 0.85 1.5125 ± 0.6575 1.38 ± 0.02 0.325 ± 0.19 7.835 ± 1.675
PEI/pDNA complexes 25.15 ± 0.75 21.25 ± 0.25 13 ± 0.7 14.8 ± 1.5 1.855 ± 0.235 0.651 ± 0.062
Atomic force microscopy (AFM) image of the PCFC-g-PEI/ DNA complex prepared at N/P ratio 7 Figure 5
Atomic force microscopy (AFM) image of the PCFC-
g-PEI/DNA complex prepared at N/P ratio 7.
Transfection images were shown in two cell lines Figure 6
Transfection images were shown in two cell lines. A) 
293 T; B) A549. Cells were incubated with PCFC-g-PEI/DNA 
complexes at N/P ratio 5 for 24 hours. The green fluorescent 
protein (GFP) expression was observed under fluorescent 
microscope at 5× magnification.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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reports had confirmed that high molecular weight PEI
with high gene transfection efficiency had higher signifi-
cant cytotoxicity than low molecular weight PEI [30], but
if complexes modified as PCFC, the cytotoxicity might
decreased due to some reasons, such as the presence of
biocompatible Pluronic [28], the decrease in free polymer
concentration in cells [31], and the decrease in charge of
complexes with decrease in primary amine amount.
The flow cytometry of cellular apoptosis caused by PCFC-
g-PEI and PEI also indicated that PCFC-g-PEI have lower
cytotoxicity than that of PEI 25 kD.
Of all the essays displayed, PCFC-g-PEI complexes could
be used in gene delivery system with lower toxicity and
considerable efficacy.
Many of reports had referred low molecular weight PEI
been modified have various advantages and optimization
of the reasons behind: size matters, molecular weight, zeta
or degradable. There are very few studies on high mole-
cule weight PEI modified or improved, due to the limita-
tion in clinical application. However, as a comprehensive
understanding of PEI transfer factor, the part of the high
molecular weight PEI selected to conduct a feasibility
study is necessary. And as a Pluronic block copolymer, the
advantage of Pluronic may be used in improving the bio-
compatibility and enhancing the transfection efficiency in
vitro. Following this study, we plan to regulate the molec-
ular weight of PEI and the ratio between PCFC and PEI,
and look forward to finding a series of cationic polymers
as gene delivery system in gene therapy as soon as possi-
ble, and in vivo study of such PCFC-g-PEI copolymer will
be studied in detail.
Conclusion
In this work, we have synthesized a Pluronic block copol-
ymer PCFC-g-PEI that crossed link with high weight
molecular branched PEI (bPEI, 25 kD) by multiblock poly
(ε-caprolactone)-Pluronic-poly (ε-caprolactone) (PCFC).
The aim of this study was to increase transfection effi-
ciency and cell permeability by grafting Pluronic with its
biological activities. However, the transfection efficiency
was not increased compared with bPEI 25 kD. PCFC-g-PEI
effectively reduced toxicity on 293 T and A549, and
retained considerable transfection efficiency in vitro. The
size and zeta potential of PCFC-g-PEI/DNA complexes
suggested that transfection efficiency depend on many
factors such as the molecular weight of the polycation and
the structure and biological activity agent. The Pluronic
block of this cationic complex may be a very good refer-
ence on gene transferring both in vitro and in vivo.
The flow cytometry graphs of the transfection efficiency in  two cell lines Figure 7
The flow cytometry graphs of the transfection effi-
ciency in two cell lines. (A) 293 T and (B) A549. PCFC-g-
PEI and PEI (25 KD) at optimized N/P ratios combine with 
DNA. A1 and B1 are the controls both used naked DNA, 
and A2 and B2 are the flow cytometry data that demon-
strated the transfection efficiency.
Cytotoxicity of PCFC-g-PEI and PEI (25 KD) at various con- centrations in two cell lines Figure 8
Cytotoxicity of PCFC-g-PEI and PEI (25 KD) at vari-
ous concentrations in two cell lines. (A) 293 T and (B) 
A549. Cell viability were detected by MTT assay (mean ± SD, 
n = 3). The standard deviation is shown by the error bars.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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Methods
Materials
Polyethyleneimine (PEI, Mw = 25 kDa), Pluronic 105
(poly (ethylene glycol)-poly (propylene glycol)-poly (eth-
ylene glycol), PEG-PPG-PEG, Mw = 1900). ε-Caprolac-
tone (ε-CL, Mw = 114), and glycidyl methacrylate (97%,
GMA) were purchased from Aldrich (USA). Deoxyribonu-
clease I (DNase I), Dulbecco's Modified Eagle's Medium
(DMEM) and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyltetrazolium bromide (MTT) were bought from Sigma,
USA. Dimethyl sulfoxide (DMSO), methanol, petroleum
ether, and anhydrous dichloromethane were purchased
from Chengdu KeLong Chemicals, China. All reagents
and solvents were analytical pure grade.
Synthesis of PCL-Pluronic-PCL (PCFC) copolymers
The PCL-Pluronic-PCL (PCFC) copolymers were prepared
by ring-opening copolymerization of ε-CL initiated by
Pluronic 105. PCFC copolymer was prepared by introduc-
ing calculated amount of ε-caprolactone and Pluronic 105
under nitrogen atmosphere into a dry three-necked bottle,
and several drops of Sn(Oct)2 was added. The bottle was
kept at 130°C. During polymerization, the system was
stirred slowly, and the viscosity increased with time. After
5 hours, reaction was ended, and the reaction system was
cooled to room temperature under nitrogen atmosphere.
The just-obtained PCFC copolymer was first dissolved in
methylene chloride and reprecipitated from the filtrate
using excess cold petroleum ether. Then the mixture was
filtered and vacuum dried to constant weight. The purified
PCFC copolymer was kept in air-tight bags in desiccators
before use. The reaction scheme was shown in Fig. 1-a.
Synthesis of (GMA-PCFC-GMA)
The GMA-PCFC-GMA was obtained by reaction with
PCFC and GMA. In this step, PCFC was dissolved in anhy-
drous dichloromethane and Glycidyl methacrylate
(GMA) was also added according to introducing calcu-
lated amount. The reaction mixture was stirred for 48 h at
25°C. The obtained products were reprecipitated from the
filtrate using excess cold petroleum ether for at least 4
times. The purified products were kept in air-tight bags in
desiccators before use. The reaction scheme is shown in
Fig 1-b.
Synthesis of Branched PCFC-g-PEI
At last step of this synthesis, PCFC-g-PEI was synthesized
by PEI grafted with GMA-PCFC-GMA by Michael addition
The percentage of cell apoptosis caused by PCFC-g-PEI and PEI were studied through propidium iodide (PI) staining and flow  cytometry (n = 3) Figure 9
The percentage of cell apoptosis caused by PCFC-g-PEI and PEI were studied through propidium iodide (PI) 
staining and flow cytometry (n = 3). Cell survival (%) = 1-apoptosis (%).BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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of branched PEI (25 kD) to PCFC. The reaction scheme is
shown in Fig. 1-c. Briefly, PEI and PCFC were separately
dissolved in Methanol. The PCFC solution was slowly
dropped into PEI solution by syringe with continuous stir-
ring. The reaction mixtures were maintained at 45°C with
nitrogen atmosphere and constant shaking for 48 h. Then
the vials were cooled to room temperature and were vac-
uum-dried for 2 d. The obtained PCFC-g-PEI was dis-
solved in distilled water and dialyzed using bag filter (Mw
= 50 kD) against distilled water for 72 h. After dialysis, the
PCFC-g-PEI was lyophilized.
Characterization of the macro monomer
The synthesized polymers PCL-Pluronic-PCL (PCFC),
GMA-PCFC-GMA and PCFC-g-PEI were estimated by
measuring Nuclear Magnetic Resonance (1H-NMR).
Molecular weight of the PCFC-g-PEI copolymers were
determined using SEC in combination with multiple
angle laser light scattering (MALLS). Sodium acetate-ace-
tic acid (0.5 M) was used as eluent with a flow rate of 0.6
ml/min. The refractive index detector from Merck-Hitachi
(RI-71), equipped with an 18 angle light scattering detec-
tor (DAWN EOS, GaAs Laser 690 nm, 30 mW, K5 cell)
from Wyatt Technology Corp. (Santa Barbara, CA) and in
line with the RI detector, allowed the determination of the
absolute molecular weight. The weight average MW was
determined using a Zimm plot (ASTRA software version
4.90). Refractive index increments, dn/dc, for the PCFC-g-
PEI copolymers were calculated with the same software
using the data from the RI detector and the polymer con-
centration.
Preparation of gene vector complexes
The whole coding sequence of green fluorescent protein
(GFP) was inserted into pcDNA3.1 (Invitrogen, San
Diego, CA) which contains a CMV promoter to construct
the plasmid GFP expressing green fluorescent protein.
And the pGFP solution was adjusted to 1 mg/ml. PCFC-g-
PEI/DNA complexes were prepared at N/P ratios of 1, 3, 5,
7, 10, and 15. 2 μg of pGFP and the calculated amounts of
polymers were each diluted in 100 μl of distilled water
and gently mixed. The polyplex formulation was incu-
bated at room temperature for 30 min before used.
Determination of particle size and zeta potential of PCFC-
g-PEI/DNA complexes
Particle size and zeta potential measurements of polymer/
DNA complexes were evaluated using a Malvern Zetasizer
3000 HS (Malvern, UK). Polymer/DNA complexes were
prepared in water at various N/P ratios. Before measure-
ment, the complexes were incubated at room temperature
for 10 min.
Agarose gel electrophoresis
The agarose gel electrophoresis was used to determine
capability of condensing negatively charged nucleonic
acid and protection DNA from degradation. Plasmid DNA
(pgfp-n1) was diluted to 0.1 mg/ml, cationic polymer
solutions were then added to the plasmid solutions with
the same volume at various [PEI]/[pDNA] N/P ratios and
shortly vortexed. After 10 min incubation at room temper-
ature, 10 μl complex solutions were analyzed by 1% agar-
ose gel electrophoresis (90 V, 30 min). In the part of
protection and release assay of DNA, PCFC-g-PEI/DNA
complexes and naked DNA (0.3 μg) were separately incu-
bated with DNase I (1 unit) in DNase/Mg2+ digestion
buffer consisting of 50 mM Tri-Cl, PH 7.6 and 10 mM
MgCl2 at 37°C for 15 min. Then the complexes were
treated with 4 μl of 250 mM EDTA for 15 min to inactivate
DNase I and each sample was mixed with 2 μl of 1 mg/ml
sodium heparin to release plasmid DNA. Finally, samples
were incubated at room temperature for 2 h and run aga-
rose gel electrophoresis using 1% agarose gel in TAE run-
ning buffer at 80 v for 40 min.
Atomic force microscopy (AFM)
The morphology and size of the PCFC-g-PEI/DNA com-
plexes were analyzed using atomic force microscopy
(AFM). The complex solution was prepared by mixing 2
μg of plasmid DNA with polymer solution at N/P ratio 7.
The complex solution was incubated at room temperature
for 30 min and diluted in 1 ml distilled water, and then
the complex solution was placed on mica surface and
dried at temperature. Imaging was carried out using non-
contact mode, and complexes sizes were determined by
measuring the diameters of the complexes.
In vitro transfection
For in vitro transfection, 293 T and A549 cells were cul-
tured in DMEM medium containing Gln supplemented
with 10% heated-inactivated fetal bovine serum and anti-
biotics (100 units/ml of penicillin, 100 units/ml of strep-
tomycin). Cells were grown at 37°C in humidified air
containing 5% CO2 and passage every 2–3 days. The cells
(1 × 105 per well) were plated on 6-well plated for 24 h
before transfection. Immediately before the initiation of
transfection experiments, the medium was removed from
each well and washed once with DMEM without serum
and antibiotic and treated with fresh medium with a serial
dilution of PCFC-g-PEI (25 kD). PEI/DNA complex was
performed as control. Luciferase gene was monitored 24 h
later by using Flow Cytometry (FCM).
Evaluation of cytotoxicity
The cell cytotoxicity of the PCFC-g-PEI was determined by
MTT analysis and propidium iodide (PI) staining and
flow cytometry.BMC Biotechnology 2009, 9:65 http://www.biomedcentral.com/1472-6750/9/65
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In the part of MTT assay, Cells were seeded in 96-well
plates at a density of 1 × 104 (293 T) and 2 × 104 (A549)
cells/well in 0.1 ml growth medium and incubated over-
night, and then added 0.1 ml fresh DMEM growth
medium containing a series of concentrations of PCFC-g-
PEI to each well. Untreated cells in growth media were
used as a control. Cell were incubated for 24 h and then
followed by addition of 20 μl of 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) solution
(5 mg/ml). After further incubation for 4 hours, the MTT
solution (0.5 mg/ml) was carefully removed from each
well, and 150 μl DMSO was added to dissolve the MTT
formazan crystals. The absorbance was recorded at 570
nm by an ELISA microplate reader (Bio-Rad). The cell via-
bility (%) was related to the control wells containing
untreated cells with fresh cell culture medium and was cal-
culated according to the following:
All dates are presented as the mean of there measurements
(± SD).
In the part of propidium iodide (PI) staining and flow
cytometry, cells were seeded in 6-well plates at a density of
2 × 105 (293 T) cells/well in 2 ml growth medium and
incubated overnight at 37°C under 5% CO2 until the con-
fluency reached 50~60%, and then changed the medium
with 2 ml fresh DMEM growth medium containing vari-
ous concentrations of PCFC-g-PEI to each well. Untreated
cells in growth media were used as a control. Cell were
incubated for 24 h and then collected for analysis. Sur-
vival (%) = 1 - apoptosis (%).
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